NCT02903238View on ClinicalTrials.gov

Brain Morphometry in OA Patients Treated With Duloxetine

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

December 31, 2011

Conditions
PainOsteoarthritis
Interventions
DRUG

Duloxetine

Duloxetine Delayed-Release Capsules: 30mg/day for 1 week ; 60mg/day for the remaining time

DRUG

Placebo Oral Tablet

Lactose capsule

Trial Locations (1)

60611

Northwestern University Feinberg School of Medicine, Chicago

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Northwestern University

OTHER

NCT02903238 - Brain Morphometry in OA Patients Treated With Duloxetine | Biotech Hunter | Biotech Hunter